ImmunoCellular Therapeutics's total assets for Q4 2022 were $768.80K, an increase of 7.62% from the previous quarter. IMUC total liabilities were $4.96M for the fiscal quarter, a 11.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.